Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.
about
Persistence and compliance with medication management in the treatment of overactive bladderLong-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian womenMuscarinic receptors in the bladder: from basic research to therapeutics.M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors.The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature.Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studies.Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years.Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
P2860
Q26765014-1F5C561C-2E38-42DD-B880-C43897C6DF36Q30410914-50E1DDBB-28F3-4119-A4FC-7598D7807026Q33783024-A823C0E3-5FD5-4AB1-B9B2-D5BF9B71C5ADQ34564708-340BDCF8-B59D-46E2-8DEB-795778BD0A7DQ35801020-A6368197-CB16-4F88-BA42-54831A2A9A1CQ36428471-1AD75D98-8E9D-4BDF-90F1-295263E66014Q37864717-0C4DB423-1A70-4DAA-B067-DD7E4B094B49Q39268095-7DAD904F-DB2C-444A-86F7-3EE81F328DF8Q42626930-F80436A8-2B02-4A5E-BF43-84E1A5557462Q44426277-B22F8BE0-AA1D-4BBA-97AF-269BAFC892B4Q45215936-201C9F3B-339A-4AFF-A36B-0F803FC9E12EQ53149368-1828F755-5EE4-4EBE-BA2B-826A747ECF07
P2860
Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Long-term safety of extended-r ...... ive bladder: a one-year study.
@en
Long-term safety of extended-r ...... ive bladder: a one-year study.
@nl
type
label
Long-term safety of extended-r ...... ive bladder: a one-year study.
@en
Long-term safety of extended-r ...... ive bladder: a one-year study.
@nl
prefLabel
Long-term safety of extended-r ...... ive bladder: a one-year study.
@en
Long-term safety of extended-r ...... ive bladder: a one-year study.
@nl
P2093
P356
P1476
Long-term safety of extended-r ...... ive bladder: a one-year study.
@en
P2093
Ananias Diokno
Detlef Albrecht
Gary Leach
Joseph Antoci
Linda Atkinson
Paul Sieber
Peter Sand
Richard Labasky
P356
10.1023/A:1021372426421
P577
2002-01-01T00:00:00Z